• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于结构设计有效的源自HtpG的抗……疫苗抗原

Structure based design of effective HtpG-derived vaccine antigens against .

作者信息

Ruggiero Alessia, Choi Han-Gyu, Barra Giovanni, Squeglia Flavia, Back Young Woo, Kim Hwa-Jung, Berisio Rita

机构信息

Institute of Biostructures and Bioimaging, IBB, CNR, Napoli, Italy.

Department of Microbiology and Medical Science, College of Medicine, Chungnam National University, Daejeon, South Korea.

出版信息

Front Mol Biosci. 2022 Aug 11;9:964645. doi: 10.3389/fmolb.2022.964645. eCollection 2022.

DOI:10.3389/fmolb.2022.964645
PMID:36032688
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9403545/
Abstract

Vaccine development against Tuberculosis is a strong need, given the low efficacy of the sole vaccine hitherto used, the Bacillus Calmette-Guérin (BCG) vaccine. The chaperone-like protein HtpG of is a large dimeric and multi-domain protein with promising antigenic properties. We here used biophysical and biochemical studies to improve our understanding of the structural basis of HtpG functional role and immunogenicity, a precious information to engineer improved antigens. We showed that HtpG is a dimeric nucleotide-binding protein and identified the dimerisation interface on the C-terminal domain of the protein. We also showed that the most immunoreactive regions of the molecule are located on the C-terminal and middle domains of the protein, whereas no role is played by the catalytic N-terminal domain in the elicitation of the immune response. Based on these observations, we experimentally validated our predictions in mice, using a plethora of immunological assays. As an outcome, we designed vaccine antigens with enhanced biophysical properties and ease of production, albeit conserved or enhanced antigenic properties. Our results prove the efficacy of structural vaccinology approaches in improving our understanding of the structural basis of immunogenicity, a precious information to engineer more stable, homogeneous, efficiently produced, and effective vaccine antigens.

摘要

鉴于迄今为止唯一使用的疫苗卡介苗(BCG)效力较低,开发抗结核病疫苗的需求十分迫切。结核分枝杆菌的伴侣样蛋白HtpG是一种大型二聚体多结构域蛋白,具有良好的抗原特性。我们在此利用生物物理和生化研究来增进对HtpG功能作用和免疫原性结构基础的理解,这是设计改良抗原的宝贵信息。我们表明HtpG是一种二聚体核苷酸结合蛋白,并确定了该蛋白C末端结构域上的二聚化界面。我们还表明,该分子最具免疫反应性的区域位于蛋白的C末端和中间结构域,而催化性的N末端结构域在引发免疫反应中不起作用。基于这些观察结果,我们通过大量免疫测定在小鼠中实验验证了我们的预测。结果,我们设计出了具有增强的生物物理特性且易于生产的疫苗抗原,同时保留或增强了抗原特性。我们的结果证明了结构疫苗学方法在增进对免疫原性结构基础理解方面的有效性,这是设计更稳定、均一、高效生产且有效的疫苗抗原的宝贵信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca3/9403545/1b5381a6a1f0/fmolb-09-964645-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca3/9403545/957e7697ed21/fmolb-09-964645-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca3/9403545/1a470155208f/fmolb-09-964645-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca3/9403545/06fc16a0aba8/fmolb-09-964645-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca3/9403545/286935bba64a/fmolb-09-964645-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca3/9403545/0fcc78723931/fmolb-09-964645-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca3/9403545/63f7685ab8b6/fmolb-09-964645-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca3/9403545/1b5381a6a1f0/fmolb-09-964645-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca3/9403545/957e7697ed21/fmolb-09-964645-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca3/9403545/1a470155208f/fmolb-09-964645-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca3/9403545/06fc16a0aba8/fmolb-09-964645-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca3/9403545/286935bba64a/fmolb-09-964645-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca3/9403545/0fcc78723931/fmolb-09-964645-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca3/9403545/63f7685ab8b6/fmolb-09-964645-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca3/9403545/1b5381a6a1f0/fmolb-09-964645-g007.jpg

相似文献

1
Structure based design of effective HtpG-derived vaccine antigens against .基于结构设计有效的源自HtpG的抗……疫苗抗原
Front Mol Biosci. 2022 Aug 11;9:964645. doi: 10.3389/fmolb.2022.964645. eCollection 2022.
2
Structural features of HtpG and HtpG-ESAT6 vaccine antigens against tuberculosis: Molecular determinants of antigenic synergy and cytotoxicity modulation.针对结核病的HtpG和HtpG-ESAT6疫苗抗原的结构特征:抗原协同作用和细胞毒性调节的分子决定因素
Int J Biol Macromol. 2020 May 4;158:305-317. doi: 10.1016/j.ijbiomac.2020.04.252.
3
Immunogenic potential of latency associated antigens against Mycobacterium tuberculosis.潜伏相关抗原对结核分枝杆菌的免疫原性。
Vaccine. 2014 Feb 3;32(6):712-6. doi: 10.1016/j.vaccine.2013.11.065. Epub 2013 Dec 2.
4
Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.用卡介苗和一种共表达结核分枝杆菌CFP10、ESAT6、Ag85A和Ag85B的重组腺病毒进行初免-加强免疫接种可在小鼠中诱导强烈的抗原特异性免疫反应。
Mol Med Rep. 2015 Aug;12(2):3073-80. doi: 10.3892/mmr.2015.3770. Epub 2015 May 12.
5
Using a prime and pull approach, lentivector vaccines expressing Ag85A induce immunogenicity but fail to induce protection against Mycobacterium bovis bacillus Calmette-Guérin challenge in mice.采用预激发和激发方法,表达Ag85A的慢病毒载体疫苗可诱导免疫原性,但无法在小鼠中诱导针对卡介苗(Mycobacterium bovis bacillus Calmette-Guérin)攻击的保护作用。
Immunology. 2015 Oct;146(2):264-70. doi: 10.1111/imm.12498. Epub 2015 Aug 18.
6
Immunogenicity and protective efficacy of prime-boost regimens with recombinant (delta)ureC hly+ Mycobacterium bovis BCG and modified vaccinia virus ankara expressing M. tuberculosis antigen 85A against murine tuberculosis.重组(δ)ureC hly+牛分枝杆菌卡介苗与表达结核分枝杆菌抗原85A的改良安卡拉痘苗病毒的初免-加强免疫方案对小鼠结核病的免疫原性和保护效力
Infect Immun. 2009 Feb;77(2):622-31. doi: 10.1128/IAI.00685-08. Epub 2008 Dec 8.
7
Systematic Evaluation of Mycobacterium tuberculosis Proteins for Antigenic Properties Identifies Rv1485 and Rv1705c as Potential Protective Subunit Vaccine Candidates.系统评估结核分枝杆菌蛋白的抗原特性,鉴定出 Rv1485 和 Rv1705c 为潜在的保护性亚单位疫苗候选物。
Infect Immun. 2021 Feb 16;89(3). doi: 10.1128/IAI.00585-20.
8
Immunological properties of recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing fusion protein IL-2-ESAT-6.表达融合蛋白IL-2-ESAT-6的重组牛分枝杆菌卡介苗菌株的免疫学特性
Acta Biochim Biophys Sin (Shanghai). 2006 Oct;38(10):683-90. doi: 10.1111/j.1745-7270.2006.00217.x.
9
Prime-boost bacillus Calmette-Guérin vaccination with lentivirus-vectored and DNA-based vaccines expressing antigens Ag85B and Rv3425 improves protective efficacy against Mycobacterium tuberculosis in mice.用表达抗原Ag85B和Rv3425的慢病毒载体疫苗和DNA疫苗进行初免-加强卡介苗接种可提高小鼠对结核分枝杆菌的保护效力。
Immunology. 2014 Oct;143(2):277-86. doi: 10.1111/imm.12308.
10
Modulation of host immune responses by overexpression of immunodominant antigens of Mycobacterium tuberculosis in bacille Calmette-Guérin.卡介苗中结核分枝杆菌免疫显性抗原的过表达对宿主免疫反应的调节
Scand J Immunol. 2003 Oct;58(4):449-61. doi: 10.1046/j.1365-3083.2003.01321.x.

引用本文的文献

1
Novel fusion protein REA induces robust prime protection against tuberculosis in mice.新型融合蛋白REA可在小鼠中诱导强大的针对结核病的初始保护作用。
NPJ Vaccines. 2025 Jan 31;10(1):20. doi: 10.1038/s41541-025-01077-1.
2
HtpG-A Major Virulence Factor and a Promising Vaccine Antigen against .HtpG-A主要毒力因子以及一种有前景的抗……疫苗抗原
Biomolecules. 2024 Apr 11;14(4):471. doi: 10.3390/biom14040471.
3
Virulence Factors in Infection: Structural and Functional Studies.感染中的毒力因子:结构与功能研究。

本文引用的文献

1
ColabFold: making protein folding accessible to all.ColabFold:让蛋白质折叠变得人人可用。
Nat Methods. 2022 Jun;19(6):679-682. doi: 10.1038/s41592-022-01488-1. Epub 2022 May 30.
2
The WHO Global Tuberculosis 2021 Report - not so good news and turning the tide back to End TB.世界卫生组织 2021 年全球结核病报告——不容乐观的消息与遏制结核病蔓延的努力
Int J Infect Dis. 2022 Nov;124 Suppl 1:S26-S29. doi: 10.1016/j.ijid.2022.03.011. Epub 2022 Mar 20.
3
Highly accurate protein structure prediction with AlphaFold.利用 AlphaFold 进行高精度蛋白质结构预测。
Biomolecules. 2023 Jul 31;13(8):1201. doi: 10.3390/biom13081201.
4
ESAT-6 a Major Virulence Factor of .ESAT-6 是 … 的主要毒力因子。
Biomolecules. 2023 Jun 9;13(6):968. doi: 10.3390/biom13060968.
5
A Structural View at Vaccine Development against .针对. 的疫苗开发的结构视角。
Cells. 2023 Jan 14;12(2):317. doi: 10.3390/cells12020317.
Nature. 2021 Aug;596(7873):583-589. doi: 10.1038/s41586-021-03819-2. Epub 2021 Jul 15.
4
Rational Vaccine Design in Times of Emerging Diseases: The Critical Choices of Immunological Correlates of Protection, Vaccine Antigen and Immunomodulation.新发疾病时代的合理疫苗设计:保护的免疫相关指标、疫苗抗原及免疫调节的关键抉择
Pharmaceutics. 2021 Apr 6;13(4):501. doi: 10.3390/pharmaceutics13040501.
5
PE_PGRS33, an Important Virulence Factor of and Potential Target of Host Humoral Immune Response.PE_PGRS33, 一种重要的毒力因子和宿主体液免疫反应的潜在靶标。
Cells. 2021 Jan 15;10(1):161. doi: 10.3390/cells10010161.
6
Safety and Immunogenicity of the GamTBvac, the Recombinant Subunit Tuberculosis Vaccine Candidate: A Phase II, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study.重组亚单位结核疫苗候选物GamTBvac的安全性和免疫原性:一项II期、多中心、双盲、随机、安慰剂对照研究。
Vaccines (Basel). 2020 Nov 3;8(4):652. doi: 10.3390/vaccines8040652.
7
Fusion of Dendritic Cells Activating Rv2299c Protein Enhances the Protective Immunity of Ag85B-ESAT6 Vaccine Candidate against Tuberculosis.激活Rv2299c蛋白的树突状细胞融合增强了候选疫苗Ag85B-ESAT6对结核病的保护性免疫。
Pathogens. 2020 Oct 22;9(11):865. doi: 10.3390/pathogens9110865.
8
Nonredundant functions of Mycobacterium tuberculosis chaperones promote survival under stress.结核分枝杆菌伴侣蛋白的非冗余功能促进其在应激下的存活。
Mol Microbiol. 2021 Feb;115(2):272-289. doi: 10.1111/mmi.14615. Epub 2020 Nov 3.
9
Antigen-Specific IFN-γ/IL-17-Co-Producing CD4 T-Cells Are the Determinants for Protective Efficacy of Tuberculosis Subunit Vaccine.抗原特异性干扰素-γ/白细胞介素-17共产生的CD4 T细胞是结核亚单位疫苗保护效力的决定因素。
Vaccines (Basel). 2020 Jun 11;8(2):300. doi: 10.3390/vaccines8020300.
10
NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data.NetMHCpan-4.1 和 NetMHCIIpan-4.0:通过同时对基序进行分解以及整合 MS MHC 洗脱配体数据,改进了 MHC 抗原呈递的预测。
Nucleic Acids Res. 2020 Jul 2;48(W1):W449-W454. doi: 10.1093/nar/gkaa379.